NEW YORK, July 25 - Genmab of Copenhagen announced today that it would issue 247,000 new shares of the company to GenPharm, a subsidiary of Medarex, leaving the Princeton, N.J.-based company with 32 percent ownership of Genmab.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?Login Now.
The New York Times Magazine examines gender discrimination at the Salk Institute.
Science reports that MD Anderson Cancer Center has dismissed three researchers over foreign tie concerns.
A second death in gene therapy trial for type 1 spinal muscular atrophy is under investigation, according to Reuters.
In PLOS this week: antibiotic resistance patterns in Escherichia coli, a dozen genetic loci tied to varicose vein risk, and more.